Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × tremelimumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 10 Carcinoma, Non-Small-Cell Lung 5 Liver Neoplasms 4 Small Cell Lung Carcinoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Seminoma 1 Pancreatic Neoplasms 1 Nonseminomatous germ cell tumor 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms, Germ Cell and Embryonal 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma 1 Lung Cancer Metastatic 1 Liver Cirrhosis 1 Hydronephrosis 1 Germinoma 1 Fallopian Tube Neoplasms 1 Dysgerminoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Adenocarcinoma, Follicular 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 5 Injections 4 Bevacizumab 4 Pemetrexed 3 Oxaliplatin 3 Leucovorin 3 Fluorouracil 3 Docetaxel 3 Carboplatin 3 trifluridine tipiracil drug combination 2 Paclitaxel 2 Irinotecan 2 Cetuximab 2 tislelizumab 1 sotorasib 1 palbociclib 1 olaparib 1 netrin-1 inhibitor NP137 1 fludarabine 1 cemiplimab 1 Panitumumab 1 Nivolumab 1 Itraconazole 1 HMPL-013 1 Fulvestrant 1 Etoposide 1 Drug Therapy 1 Cyclophosphamide 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡